Teleflex's (NYSE: TFX) fourth-quarter 2024 earnings conference call, held on February 27, 2025, revealed significant ...
Biotronik today announced a strategic shift that includes the divestiture of its Vascular Intervention (VI) business to ...
Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...
Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...
Medical devices provider, Teleflex ( NYSE: TFX) said on Thursday that it will acquire all of the vascular intervention ...
Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...
In a flurry of news releases on Feb. 27, Teleflex Inc. reported plans to buy the vascular intervention business of Biotronik ...
Teleflex (TFX) announced it has entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of ...
3 “We are excited to announce the acquisition of BIOTRONIK’s Vascular Intervention business, which we anticipate will significantly enhance our global presence in the cath lab, expand our ...
GlobalData on MSN12d
Teleflex to split into two separate entitiesTeleflex is splitting its business into two independently traded entities, with a completion date set for mid-2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback